Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

GZPHF
Guangzhou Baiyunshan Pharmaceutical Holdings Company LimitedUS flagOther OTC
2.34
USD
- -
- -
6.20BMarket Cap

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GZPHF) Stock Split History

Learn about Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's most recent 10031-for-10000 basis stock split on January 28, 2014. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's most recent stock split

Split Date: 2014-01-28
Split Ratio: 10031:10000
Price Before Split: $4.01
Price After Split: $4.00

Developer API

Get GZPHF split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/GZPHF

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 1.00 times more shares (a 10031:10000 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2014-01-2810031:10000No$4.01$4.00

About Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

Company overview and industry information

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GZPHF) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 10031-for-10000 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Drug Manufacturers - Specialty & Generic
Go to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Summary

Last updated: 7/11/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.